Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-08

Clinical Trial Update: Suzetrigine for Acute Pain Control in Patients With Multiple Rib Fractures [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating Suzetrigine for acute pain control in patients with multiple rib fractures is currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Suzetrigine (Suzetrigine)

Snippet

Sponsor: University of California, Irvine | Conditions: Rib Fractures | Phase 4 | Status: ENROLLING_BY_INVITATION